Home › Stroke › NCT07356011
Exoskeleton for Balance
Recruiting
Improving Mediolateral Walking Balance With an Assistive Exoskeleton
Who can join
Ages 21 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Evidence of a stroke at least 6 months prior to participation * Evidence of dysfunction of the paretic lower limb (Fugl-Meyer lower extremity motor score \< 34) * At least 21 years of age * Self-reported experience of a fall in the previous year, and/or a fear of falling * Gait speed of at least 0.2 m/s * Ability to walk on a treadmill without a cane or walker * Ability to follow three step commands and communicate with experimenters to answer questions (e.g., regarding their balance confidence) * Provision of informed consent Exclusion Criteria: * Resting blood pressure higher than 220/110 mm Hg * History of unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living * Preexisting neurological orders or dementia * Legal blindness or severe visual impairment * Presence of neglect * History of DVT or pulmonary embolism within 6 months * Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions * Orthopedic injuries or conditions (e.g., joint replacements) in the lower extremities with the potential to alter the gait pattern
About the study
Many people who have experienced a stroke have deficits in their walking balance. The long-term goal of this research is to develop an exoskeleton that can effectively improve walking balance, thus improving functional mobility.
What is being tested
- No Exoskeleton (device)
- Exoskeleton (zero impedance) (device)
- Exoskeleton (low impedance) (device)
- Exoskeleton (medium impedance) (device)
- Exoskeleton (high impedance) (device)
Sponsor: Medical University of South Carolina · Participants: 21 · Started: May 6, 2026
Contact the study team
- Jesse C. Dean, PhD · Phone: 8437929566
Official record on ClinicalTrials.gov — NCT07356011
Locations in the U.S.
| South Carolina | Medical University of South Carolina, Charleston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.